Moreover, given the established influence of age, smoking, environmental exposures, and other clinical variables on DNA methylation, future studies should incorporate multivariate regression models to adjust these covariates, thereby enabling more precise screening and identification of disease-specific epigenetic signatures, including the assessment of SPARC methylation as an independent biomarker for IPF. Here, SPARC is linked to idiopathic pulmonary fibrosis.